Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Further research is warranted to optimize PONV prophylaxis in cardiac surgery patients.
2
We investigated the incidences of PONV, the frequency of using the antiemetics.
3
However it is not clear whether continuous epidural administration of doroperidol prevent PONV.
4
Conclusions: The results suggest that epidural droperidol effectively decreases PONV in high risk patients.
5
All episodes of postoperative PONV during the first 24 h after surgery were evaluated.
6
The authors tested the effect of neuromuscular monitoring over the P6 acupuncture point on the reduction of PONV.
7
PECS block can reduce intraoperative use of opioids and analgesic drugs, and is associated with reduced occurrence of PONV.
8
However, in contrast to other surgical populations, routine PONV prophylaxis is not a standard of care in cardiac surgery.
9
The primary outcome was the incidence of PONV in the first 24 hours postextubation, compared by the χ test.
10
Conclusion: Preoperative intravenous glucocorticoids are an effective and safe method to reduce postoperative pain and PONV in patients following TKA.
11
However, the superiority of clonidine for PONV prevention remains unclear while other factors such as nausea prevention might interfere with this result.
12
We report on the efficiency of granisetron and tropisetron, with that of placebo on the prevention of PONV in patients undergoing total thyroidectomy.
13
It has been reported that epidural adrenaline decreases PONV; therefore we prospectively compared the effectiveness of epidural droperidol and adrenaline for prophylaxis of PONV.
14
Study objective: To compare the incidence of postoperative nausea and vomiting (PONV) during perioperative administration of 5% dextrose and normal saline in laparoscopic cholecystectomy.
15
The incidence of PONV was reduced by 38% in group D which is significantly lower when compared with that of group NS (p value 0.001).
16
Further research is warranted to optimize PONV prophylaxis in cardiac surgery patients.